会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • DINUCLEOSIDE-5',5'-PYROPHOSPHATES
    • 二核苷-5' ,5'-焦磷酸盐
    • WO1996002554A1
    • 1996-02-01
    • PCT/EP1995002676
    • 1995-07-10
    • GRUPPO LEPETIT S.P.A.UNIVERSITA' DEGLI STUDI DI GENOVADE FLORA, AntonioBENATTI, UmbertoGIOVINE, Marco
    • GRUPPO LEPETIT S.P.A.UNIVERSITA' DEGLI STUDI DI GENOVA
    • C07H21/00
    • C07H21/00
    • 5',5'-Pyrophosphates of non-naturally occurring nucleosides selected from thymine-3'-azido-2',3'-dideoxy-D-riboside, 5-fluorouracil-2'-deoxy-D-riboside, uracil-3'-azido-2',3'-dideoxy-D-riboside, guanine-2',3'-dideoxy-D-riboside, hypoxanthine-2',3'-dideoxy-D-riboside, cytosine-2',3'-dideoxy-D-riboside, and adenine-2',3'-dideoxy-D-riboside, are described as well as their manufacture and use as therapeutical agents against tumors and retroviral infections including HIV infections. The compounds may be administered as the active ingredients of pharmaceutical compositions or as pro-drugs encapsulated into biological carriers, e.g., transformed erythrocytes, for targeting to specific cell population responsible of the development of the pathological disorders.
    • 选自胸腺嘧啶-3'-叠氮基-2',3'-二脱氧-D-核糖苷,5-氟尿嘧啶-2'-脱氧-D-核糖核苷,尿嘧啶-3的非天然存在的核苷的5',5'-焦磷酸 '叠氮基-2',3'-二脱氧-D-核糖苷,鸟嘌呤-2',3'-二脱氧-D-核糖,次黄嘌呤-2',3'-二脱氧-D-核糖,胞嘧啶-2',3 描述了'二脱氧-D-核糖苷和腺嘌呤-2',3'-二脱氧-D-核糖核苷,以及它们作为抗肿瘤和逆转录病毒感染(包括HIV感染)的治疗剂的制备和用途。 化合物可以作为药物组合物的活性成分或作为包封在生物载体例如转化的红细胞中的前体药物施用,用于靶向负责病理性疾病发展的特定细胞群。